A. Brian Davis

CIK: 0001184432

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GRCE

Grace Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

GRCE
Grace Therapeutics, Inc.
Sep 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
0 shares-
GRCE
Grace Therapeutics, Inc.
Jan 8, 2026
Award(A)
Stock Option (Right to Buy)
Direct
10K shares-
GRCE
Grace Therapeutics, Inc.
May 9, 2025
Award(A)
Stock Option (Right to Buy)
Direct
10K shares-

		Type	Shares	Price		Ownership
Sep 17, 2026	GRCE Grace Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	0	-	-	Direct
Jan 8, 2026	GRCE Grace Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	10,000	-	-	Direct
May 9, 2025	GRCE Grace Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	10,000	-	-	Direct

1-3 of 3 transactions

About DAVIS A BRIAN

DAVIS A BRIAN (SEC CIK 0001184432) files insider reports with the SEC as Director of Grace Therapeutics, Inc. (GRCE).

Signal8 holds 3 ownership filings by DAVIS A BRIAN, all Form 4s, filed between May 13, 2025 and Sep 21, 2026. Those filings report 3 transactions, from May 9, 2025 to Sep 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on DAVIS A BRIAN's filings is in PRINCETON, NJ.

Recent filings by DAVIS A BRIAN

Sep 17, 2026: Grant or award of GRCE derivative securities (Form 4, code A).
Jan 8, 2026: Grant or award of GRCE derivative securities (Form 4, code A).
May 9, 2025: Grant or award of GRCE derivative securities (Form 4, code A).

Other insiders filing for Grace Therapeutics, Inc. (GRCE)

Opaleye Management Inc., 10% Owner
NEUGEBOREN EDWARD, Director
Kavuru Vimal, Director
Kottayil George, Director
Kohli Prashant, Chief Executive Officer
Kumar Amresh, VP Program Management

How to read Form 4 transaction codes